Optimisation of ASthma In those with uncontrolled Symptoms (OASIS)
Research type
Research Study
Full title
Optimisation of ASthma In those with uncontrolled Symptoms (OASIS) in primary care using a digital consultation tool for telephone or video consultations during the COVID pandemic.
IRAS ID
274450
Contact name
David Jackson
Contact email
Sponsor organisation
Guy's and St Thomas' NHS Foundation Trust
Duration of Study in the UK
1 years, 5 months, 29 days
Research summary
Asthma is a long term breathing condition caused by inflammation in the airways, associated with recurrent episodes of wheezing, breathlessness and chest tightness. Symptoms vary in frequency and severity. Most patients can be effectively managed with inhaled medications alone. However, many remain difficult to control for a variety of correctable reasons including sub-optimal usage of medications and poor inhaler technique. Others continue to experience regular symptoms and suffer with asthma attacks despite optimal treatment and would benefit from onward referral to a specialist clinic in secondary care. It is often challenging to distinguish between patients with ‘difficult asthma’ and those with ‘severe asthma’. A digital tool has therefore been developed to assist the healthcare professional in providing optimal care in the GP practices and hot clinic (referred post A&E attendance) whilst also identifying severe asthmatics who need referral.
This is become even more important due to the increased risk of COVID-19-related hospital death for patients with asthma who had an asthma attack requiring oral corticosteroids.
This study aims to validate the use of a digital tool to review asthmatics. Patients who have experienced 1 or more asthma attacks in the previous year will be invited to participate in the study. These patients will be identified using the general practice database or those that have attended A&E for their asthma. Patients will be randomised to receive usual care or a consultation using the tool. A comparison of clinical outcomes including assessment of disease control, quality of life and frequency of asthma attacks will be made. The study will aim to recruit 250 patients in each arm in primary care and 50 patients in each arm from A&E over a 12 month period.
REC name
London - Chelsea Research Ethics Committee
REC reference
21/LO/0468
Date of REC Opinion
23 Jul 2021
REC opinion
Further Information Favourable Opinion